154 related articles for article (PubMed ID: 7336969)
1. Preliminary studies on the absorption, distribution, metabolism, and excretion of THIP in animal and man using 14C-labelled compound.
Schultz B; Aaes-Jørgensen T; Bøgesø KP; Jørgensen A
Acta Pharmacol Toxicol (Copenh); 1981 Aug; 49(2):116-24. PubMed ID: 7336969
[TBL] [Abstract][Full Text] [Related]
2. Absorption, distribution, metabolism and excretion of a new, 14C-labelled oxazolidinone MAO-A inhibitor in rat and dog.
Naitoh T; Mishima M; Kawaguchi S; Matsui K; Andoh T; Kagei K; Kakiki M; Yuzuriha T; Horie T
Xenobiotica; 1997 Oct; 27(10):1053-70. PubMed ID: 9364742
[TBL] [Abstract][Full Text] [Related]
3. Absorption, distribution and excretion of 3-(sulfamoyl[14C]methyl)-1,2-benziosoxazole (AD-810) in Rats, Dogs and Monkeys and of AD-810 in Men.
Matsumoto K; Miyazaki H; Fujii T; Kagemoto A; Maeda T; Hashimoto M
Arzneimittelforschung; 1983; 33(7):961-8. PubMed ID: 6138046
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of labetalol by animals and man.
Martin LE; Hopkins R; Bland R
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
[TBL] [Abstract][Full Text] [Related]
5. Metabolic disposition of 14C-labelled Brown HT in the rat, mouse and guinea-pig.
Phillips JC; Mendis D; Gaunt IF
Food Chem Toxicol; 1987 Dec; 25(12):1013-9. PubMed ID: 3692393
[TBL] [Abstract][Full Text] [Related]
6. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
7. Metabolic disposition of 14C-labelled carmoisine in the rat, mouse and guinea-pig.
Phillips JC; Bex C; Walters DG; Gaunt IF
Food Chem Toxicol; 1987 Dec; 25(12):927-35. PubMed ID: 3692400
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous absorption of 14C-labelled 2-chlorobenzaldehyde in rats. Metabolism and toxicokinetics.
Rietveld EC; Hoet RM; Seutter-Berlage F; Van Rossum JM
Eur J Drug Metab Pharmacokinet; 1988; 13(4):231-40. PubMed ID: 3243317
[TBL] [Abstract][Full Text] [Related]
9. Enzymic synthesis of two glucuronides of the hydroxyisoxazole GABA-agonist, THIP, and the in vivo glucuronidation of THIP in rat.
Andersen JV; Dalgaard L; Hansen SH
Xenobiotica; 1989 Dec; 19(12):1399-406. PubMed ID: 2618090
[TBL] [Abstract][Full Text] [Related]
10. [Distribution, metabolism and excretion of 14C-MT-141 in rats. I. Distribution, metabolism and excretion after single intravenous administration in male rats].
Komiya I; Ishizuka T; Nishio M; Murata S; Esumi Y; Washino T; Matsunaga K; Mitsugi K; Yokoshima T
Jpn J Antibiot; 1984 May; 37(5):927-37. PubMed ID: 6434764
[TBL] [Abstract][Full Text] [Related]
11. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
[TBL] [Abstract][Full Text] [Related]
12. The metabolic disposition of 14C-labelled carmoisine in the rat after oral and intravenous administration.
Galli CL; Marinovich M; Costa LG
Food Chem Toxicol; 1982 Aug; 20(4):351-6. PubMed ID: 6890016
[TBL] [Abstract][Full Text] [Related]
13. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
14. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
15. The absorption, tissue distribution and excretion of di-n-octyltin dichloride in rats.
Penninks AH; Hilgers L; Seinen W
Toxicology; 1987 Apr; 44(1):107-20. PubMed ID: 3564046
[TBL] [Abstract][Full Text] [Related]
16. Observations on the absorption, distribution, metabolism, and excretion of the dopamine (D2) agonist, quinelorane, in rats, mice, dogs, and monkeys.
Manzione BM; Bernstein JR; Franklin RB
Drug Metab Dispos; 1991; 19(1):54-60. PubMed ID: 1673422
[TBL] [Abstract][Full Text] [Related]
17. 14C-NaVP and 14C-PEV repeated dose study in rat. Pharmacokinetic study in rats after repeated oral administrations of 14C-valproic acid sodium salt and 14C-valproic acid pivaloyl oxymethyl ester.
Bertolino M; Acerbi D; Canali S; Giachetti C; Poli G; Ventura P; Zanolo G
Eur J Drug Metab Pharmacokinet; 1998; 23(2):223-9. PubMed ID: 9725486
[TBL] [Abstract][Full Text] [Related]
18. Metabolic disposition of 14C-labelled amaranth in the rat, mouse and guinea-pig.
Phillips JC; Bex CS; Mendis D; Walters DG; Gaunt IF
Food Chem Toxicol; 1987 Dec; 25(12):947-54. PubMed ID: 3692402
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of the gamma-aminobutyric acid agonist THIP (Gaboxadol) following intramuscular administration to man, with observations in dog.
Madsen SM; Lindeburg T; Følsgård S; Jacobsen E; Sillesen H
Acta Pharmacol Toxicol (Copenh); 1983 Nov; 53(5):353-7. PubMed ID: 6659963
[TBL] [Abstract][Full Text] [Related]
20. The disposition of 14C-indapamide in man.
Klunk LJ; Ringel S; Neiss ES
J Clin Pharmacol; 1983; 23(8-9):377-84. PubMed ID: 6630587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
